ConductScience.org, home

Paper34097166

Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.

Rocchi C and 5 others. Dig Dis Sci, 2022. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review. Papers, record 34097166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34097166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
PubMed
Journal
Dig Dis Sci
PubMed
Year
2022
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rocchi CChiara
2Soliman YYYoussef Y
3Massidda MMarco
4Vadalà di Prampero SFSalvatore F
5Bulajic MMilutin
6Sorrentino DDariohttps://orcid.org/0000-0001-5758-5845

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colitis, UlcerativeMajor topic
Colonic PouchesMajor topic
Crohn DiseaseMajor topic
PouchitisMajor topic
Proctocolectomy, RestorativeMajor topic
Humans
Retrospective Studies
Ustekinumab

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124876789Measuring disease activity in Crohn's disease: what is currently available to the clinician.Clin Exp Gastroenterol2014https://conductscience.org/library/papers/24876789PubMed
28624195Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.Arch Surg1996https://conductscience.org/library/papers/8624195PubMed
332199882Efficacy of IL12/23 Blockade Expands Our Therapeutic Targets and Challenges the Old Dogma in Ulcerative Colitis.Gastroenterology2020https://conductscience.org/library/papers/32199882PubMed
431136680Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31136680PubMed
522875487Efficacy of biologic therapy in patients with chronic pouchitis.Int J Colorectal Dis2013https://conductscience.org/library/papers/22875487PubMed
629688479Ustekinumab Treatment in Crohn's Disease of Barnett Continent Intestinal Reservoir.Inflamm Bowel Dis2018https://conductscience.org/library/papers/29688479PubMed
732067061Ileal pouch-anal anastomosis in ulcerative colitis: outcomes, functional results, and quality of life in patients with more than 10-year follow-up.Int J Colorectal Dis2020https://conductscience.org/library/papers/32067061PubMed
820047579Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis.Aliment Pharmacol Ther2010https://conductscience.org/library/papers/20047579PubMed
99351572Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis.Am J Surg Pathol1997https://conductscience.org/library/papers/9351572PubMed
1012072630Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up.Dis Colon Rectum2002https://conductscience.org/library/papers/12072630PubMed
1130810748Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.Inflamm Bowel Dis2019https://conductscience.org/library/papers/30810748PubMed
1229867171Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials.Am J Gastroenterol2018https://conductscience.org/library/papers/29867171PubMed
1324714229The role of antibiotics and probiotics in pouchitis.Ann Gastroenterol2012https://conductscience.org/library/papers/24714229PubMed
1428008631Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm.Aliment Pharmacol Ther2017https://conductscience.org/library/papers/28008631PubMed
1527959607Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.N Engl J Med2016https://conductscience.org/library/papers/27959607PubMed
1627057684Crohn's Disease of the Ileoanal Pouch.Inflamm Bowel Dis2016https://conductscience.org/library/papers/27057684PubMed
1727751880Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.Gastroenterology2017https://conductscience.org/library/papers/27751880PubMed
18667572Proctocolectomy without ileostomy for ulcerative colitis.Br Med J1978https://conductscience.org/library/papers/667572PubMed
1920002692Outcome and long-term function of restorative proctocolectomy for Crohn's disease: comparison to patients with ulcerative colitis.Colorectal Dis2011https://conductscience.org/library/papers/20002692PubMed
2029423578Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis.Tech Coloproctol2018https://conductscience.org/library/papers/29423578PubMed

See all 43 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
41732330Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.Ther Adv Gastroenterol2026https://conductscience.org/library/papers/41732330PubMed
39897343Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.Gastroenterol Hepatol (N Y)2025https://conductscience.org/library/papers/39897343PubMed
39600566Raising the bar in ulcerative colitis management.Ther Adv Gastroenterol2024https://conductscience.org/library/papers/39600566PubMed
38664536Pouchitis: pathophysiology and management.Nat Rev Gastroenterol Hepatol2024https://conductscience.org/library/papers/38664536PubMed
38592377Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms.J Clin Med2024https://conductscience.org/library/papers/38592377PubMed
36844648Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.Curr Treat Options Gastroenterol2022https://conductscience.org/library/papers/36844648PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL23A51561PubTator's text mininghttps://conductscience.org/library/genes/51561NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34097166

GET https://conductscience.org/api/papers/v1/34097166/references?page=2